Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome

Annals of the Rheumatic Diseases

Volumn 65, Issue 3, 2006, Pages 348-353

  Douglas, K M J ^b   Pace, A V ^b   Treharne, G J ^b   Saratzis, A ^b   Nightingale, P ^c   Erb, N ^b   Banks, M J ^b   Kitas, George D ^a,c  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; STEROID;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAPSE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; THORAX PAIN; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ARTHRITIS, RHEUMATOID; CORONARY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; RECURRENCE; SYNDROME;

EID: 33144455144     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.037978     Document Type: Article

References (47)

1. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
2. Goodson N. Coronary artery disease in rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115-20.
3. Kitas GD, Banks M, Bacon PA. Cardiac involvement in rheumatoid disease. Clin Med 2001;1:18-21.
4. Mutru O, Laakso M, Isomaki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ 1985;290:1797-9.
5. Myllykangas-Luosujarvi R, Isomaki H, Koota K. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
6. Wȧllberg-Jonsson S, Ohman ML, Rantapaa-Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive RA in northern Sweden. J Rheumatol 1997;24:445-51.
7. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol 1999;26:2475-9.
8. del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by classical risk factors. Arthritis Rheum 2001;44:2737-45.
9. Banks M, Flint J, Bacon PA, Kitas GD. Rheumatoid arthritis is an independent risk factor for ischaemic heart disease [abstract]. Arthritis Rheum 2000;43(suppl 9):S385.
10. Herlitz J, Karlson BW, Sjolin M, Lindqvist J. Ten year mortality in subsets of patients with an acute coronary syndrome. Heart 2001;86:391-6.
11. Arnett FC, Edwarthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Fox KAA, Birkhead J, Wilcox R, Knight C, Barth J. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004;90:603-9.
13. Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457-65.
14. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003;42:607-13.
15. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
16. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
17. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
18. Bacon PA, Raza K, Banks MJ, Townend J, Kitas GD. The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int Rev Immunol 2002;21:1-17.
19. Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-9.
20. Wȧllberg-Jonsson S, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001;28:2597-602.
21. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003;62:414-18.
22. del Rincon I, Haas RW, Pogosian S, Escalante A. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis 2005;64:425-32.
23. Smith SC. Risk-reduction therapy: the challenge to change. Presented at the 68th Scientific Sessions of the American Heart Association November 13, 1995 Anaheim, California. Circulation 1996;93:2205-11.
24. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-67.
25. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989;170:1595-608.
26. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1991;11:1223-30.
27. van der Wal AC, Piek JJ, de Boer OJ, Koch KT, Teeling P, van der Loos CM, et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998;80:14-18.
28. Kitas GD, Salmon M, Farr M, Gaston JS, Bacon PA. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Clin Exp Immunol 1988;73:242-9.
29. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;l01:2883-8.
30. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function or CD4 T cells in acute coronary syndromes. Circ Res 2003;93:106-13.
31. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004;109:2744-8.
32. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, et al. T-Cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002;105:570-5.
33. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003;96:793-807.
34. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7.
35. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
36. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094-9.
37. Veldhuijzen van Zanten JJ, Ring C, Carroll D, Kitas GD. Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:1299-304.
38. McEntegart A, Capell HA, Creran D, Rumlev A, Woodward M, Lowe GDO. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001;40:640-4.
39. Wȧllberg-Jonsson S, Cederfelt M, Rantapaa-Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year follow up study. J Rheumatol 2000;27:71-5.
40. Treharne GJ, Hale ED, Lyons AC, Booth DA, Banks MJ, Erb N, et al. Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients. Rheumatology 2005;44:241-6.
41. Dorsch MF, Lawrance RA, Sapsford RJ, Durham N, Oldham J, Greenwood DC, et al. Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain. Hearf 2001;86:494-8.
42. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-7.
43. Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen U. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004;22:63-70.
44. Banks M, Kitas G. Patients' physical disability may influence doctors' perceptions of suitability for risk assessment of CHD. BMJ 1999;319:1266a.
45. Basu S, Senior R, Dore C, Lahiri A. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients. BMJ 1996;313:844-8.
46. Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774-9.
47. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21.